Biocon reply to clarification sought by the exchange

24 Aug 2015 Evaluate

With reference to the news item appearing on Business Standard on August 22, 2015 titled ‘USFDA observations’, Biocon has clarified that USFDA conducts audit at regular intervals. Biocon underwent such inspection in June 2015, wherein a few minor observations in the nature of recommendations were made by the regulatory team. All those have been considered by the Company and closed out with the FDA. None of the USFDA observations were material in nature to have bearing on operation / performance of the Company or price sensitive in nature.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

395.25 -2.80 (-0.70%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×